Sunshine Biopharma (SBFMW) Cash from Investing Activities Growth (3y) (2018 - 2026)
Sunshine Biopharma (SBFMW) Cash from Investing Activities Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 8.16% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 26.15% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 75.05% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -129.09% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -2.94% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -212.48% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 37.22% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | -98.10% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | 10.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.61% |
| Dec 31, 2025 | 84.91% |
| Dec 31, 2023 | -783.04% |
| Sep 30, 2023 | 194.62% |
| Dec 31, 2022 | -2,471.25% |
| Dec 31, 2020 | 83.30% |
| Sep 30, 2020 | -26.74% |
| Dec 31, 2019 | 7.76% |
| Jun 30, 2019 | -76.93% |
| Dec 31, 2018 | 26.28% |